Fig. 1From: Patient and caregiver experiences with pantothenate kinase-associated neurodegeneration (PKAN): results from a patient community surveyFirst symptoms experienced by respondents according to PKAN phenotype. Respondents (N = 166) were grouped into classic (pink, n = 85) and atypical (green, n = 65) PKAN phenotype groups based on their reported age of onset (classic, < 10 years). Respondents who were unable to provide an age of onset were grouped as “not sure” (purple, n = 16). PKAN = pantothenate kinase-associated neurodegenerationBack to article page